Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Liesbeth Van Hijfte

Publications & Research Data

Awards & Distinctions

30 Results

2025

Beyond the cut-off : harmonizing kappa free light chain index using likelihood ratios improves the clinical interpretation in the diagnosis of multiple sclerosis

Matthijs OyaertLouis NevejanCathérine DekeyserPieter De KeselMelissa CambronLudo VanopdenboschLiesbeth Van HijfteGuy LaureysMartine Vercammen

Editorial material

First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis

Simona ToscanoTim SpelmanSerkan OzakbasRaed AlroughaniClara G. ChisariSalvatore Lo FermoAlexandre PratMarc GirardPierre DuquetteGuillermo Izquierdo et al.

A1 Journal Article in NEUROTHERAPEUTICS

Multiple sclerosis nursing to improve care and education (MSNICE) : an observational study

Liesbeth Van HijfteMelissa CambronRoel CrolsGino De La MeilleureNelly GoversLudo VanopdenboschGuy LaureysBarbara WillekensMaarten BuyleChantal De Barsy et al.

A1 Journal Article in BMC NURSING

Phenotyping vestibulocochlear manifestations in Susac syndrome : a cohort study

Astrid RoelensMaria VandekerckhoveLeen MaesCathérine DekeyserDimitri HemelsoetVeroniek Van DriesscheMarijke MiattonLiesbeth Van HijfteJulie De ZaeytijdTineke Van Vrekhem et al.

A1 Journal Article in EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD : a multicentre study

Pakeeran SiriratnamPaul SanfilippoAnneke van der WaltSifat SharminYi Chao FoongWei Zhen YehChao ZhuSamia Joseph KhouryTunde CsepanyBarbara Willekens et al.

A1 Journal Article in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Relationship between brain atrophy and disability in a multi-site multiple sclerosis registry

Ai-Lan NguyenDana HorakovaEva H HavrdovaMichael BarnettMaria Pia SormaniNicola De StefanoMarco BattagliniManuela VaneckovaElaine LuiFrank Gaillard et al.

A2 Journal Article in BMJ NEUROLOGY OPEN

The impact of multidisciplinary care on the health-related quality of life in people with multiple sclerosis : a systematic review

Liesbeth Van HijfteCaroline JonkersYinthe Van KerkhoveHebe WillekensGuy LaureysBarbara Willekens

A1 Journal Article in MULTIPLE SCLEROSIS AND RELATED DISORDERS

2024

Brain health oriented care in multiple sclerosis : a critical role for specialist nurses?

Liesbeth Van HijfteGuy LaureysBarbara Willekens

Cognitive outcomes in Susac syndrome : a 2-year neuropsychological follow-up study

Tineke Van VrekhemMarijke MiattonDimitri HemelsoetLiesbeth Van HijfteCathérine DekeyserJulie De ZaeytijdVeroniek Van DriesscheHelen Van HoeckeLeen MaesGuy Laureys

A1 Journal Article in EUROPEAN JOURNAL OF NEUROLOGY

Disease activity in pregnant and postpartum women with multiple sclerosis receiving ocrelizumab or other disease-modifying therapies

Wei Z. YehAnneke Van Der WaltOlga G. SkibinaTomas KalincikRaed AlroughaniAllan G. KermodeMarzena J. Fabis-PedriniWilliam M. CarrollJeannette Lechner-ScottCavit Boz et al.

A1 Journal Article in NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION

Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis : a longitudinal analysis of global and national registries

Sifat SharminIzanne RoosCharles B MalpasPietro IaffaldanoMarta SimoneMassimo FilippiEva Kubala HavrdovaSerkan OzakbasVincenzo Brescia MorraRaed Alroughani et al.

A1 Journal Article in LANCET CHILD & ADOLESCENT HEALTH

Effectiveness of cladribine compared to fingolimod, natalizumab, ocrelizumab and alemtuzumab in relapsing-remitting multiple sclerosis

Izanne RoosSifat SharminCharles MalpasSerkan OzakbasJeannette Lechner-ScottSuzanne HodgkinsonRaed AlroughaniSara Eichau MadueñoCavit BozAnneke van der Walt et al.

A1 Journal Article in MULTIPLE SCLEROSIS JOURNAL

Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis

Cathérine DekeyserPieter De KeselMelissa CambronLudo VanopdenboschLiesbeth Van HijfteMartine VercammenGuy Laureys

A1 Journal Article in FRONTIERS IN IMMUNOLOGY

Multiple sclerosis multidisciplinary care : a national survey and lessons for the global community

Liesbeth Van HijfteMelissa CambronBrigitte CapronBernard DachyDanny DecooDominique DiveBénédicte DuboisSouraya El SankariFrederic LondonGaetano Perrotta et al.

A1 Journal Article in MULTIPLE SCLEROSIS AND RELATED DISORDERS

The impact of COVID-19 infection on multiple sclerosis disease course across 12 countries : a propensity-score-matched cohort study

David LevitzYi Chao FoongPaul SanfilippoTim SpelmanLouise RathAngie RoldanAnoushka LalMastura MonifVilija JokubaitisSerkan Ozakbas et al.

A1 Journal Article in THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS

Utility of icobrain for brain volumetry in multiple sclerosis clinical practice

Ai-Lan NguyenMaria Pia SormaniDana HorakovaEva H HavrdovaMichael H BarnettNicola De StefanoMarco BattagliniManuela VaneckovaElaine LuiFrank Gaillard et al.

A1 Journal Article in MULTIPLE SCLEROSIS AND RELATED DISORDERS

2023

Atypical clinical and novel radiological findings in Susac syndrome : experience from a large monocentric cohort

Cathérine DekeyserAlexander VanhoorneDimitri HemelsoetLiesbeth Van HijfteJulie De ZaeytijdVeroniek Van DriesscheHelen Van HoeckeMarijke MiattonTineke Van VrekhemLeen Maes et al.

A1 Journal Article in JOURNAL OF NEUROIMMUNOLOGY

Comparative effectiveness of autologous hematopoietic stem cell transplant vs fingolimod, natalizumab, and ocrelizumab in highly active relapsing-remitting multiple sclerosis

Tomas KalincikSifat SharminMark S. FreedmanHarold AtkinsJoachim BurmanJennifer MasseyIan SuttonBarbara WithersRichard MacdonellAndrew Grigg et al.

A1 Journal Article in JAMA NEUROLOGY

Comparison between dimethyl fumarate, fingolimod, and ocrelizumab after natalizumab cessation

Chao ZhuTomas KalincikDana HorakovaZhen ZhouKatherine BuzzardOlga SkibinaRaed AlroughaniGuillermo IzquierdoSara EichauJens Kuhle et al.

A1 Journal Article in JAMA NEUROLOGY

Disability accrual in primary and secondary progressive multiple sclerosis

Sam Harding-ForresterIzanne RoosAi-Lan NguyenCharles B MalpasIbrahima DioufNahid MoradiSifat SharminGuillermo IzquierdoSara EichauFrancesco Patti et al.

A1 Journal Article in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis

C DaruwallaV ShaygannejadS OzakbasEK HavrdovaD HorakovaR AlroughaniC BozF PattiM OnofrjA Lugaresi et al.

A1 Journal Article in MULTIPLE SCLEROSIS JOURNAL

Rituximab vs ocrelizumab in relapsing-remitting multiple sclerosis

Izanne RoosStella HughesGavin McDonnellCharles B. MalpasSifat SharminCavit BozRaed AlroughaniSerkan OzakbasKatherine BuzzardOlga Skibina et al.

A1 Journal Article in JAMA NEUROLOGY

The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

Sifat SharminIzanne RoosSteve Simpson-YapCharles MalpasMarina M SánchezSerkan OzakbasDana HorakovaEva K HavrdovaFrancesco PattiRaed Alroughani et al.

A1 Journal Article in BRAIN

Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis

Ibrahima DioufCharles B. MalpasSifat SharminIzanne RoosDana HorakovaEva Kubala HavrdovaFrancesco PattiVahid ShaygannejadSerkan OzakbasGuillermo Izquierdo et al.

A1 Journal Article in EUROPEAN JOURNAL OF NEUROLOGY

2022

Association of latitude and exposure to ultraviolet B radiation with severity of multiple sclerosis : an international registry study

M VitkovaI DioufC MalpasD HorakovaE Kubala HavrdovaF PattiS OzakbasG IzquierdoS EichauV Shaygannejad et al.

A1 Journal Article in NEUROLOGY

Disease reactivation after cessation of disease-modifying therapy in patients with relapsing-remitting multiple sclerosis

I RoosC MalpasE LerayR CaseyD HorakovaEK HavrdovaM DebouverieF PattiJ De SezeG Izquierdo et al.

A1 Journal Article in NEUROLOGY

Lifestyle factors in multiple sclerosis disability progression and silent brain damage : a cross-sectional study

Liesbeth Van HijfteGriet LoretHelen BachmannTatjana ReyndersMarleen BreulsEllen DeschepperJens KuhleBarbara WillekensGuy Laureys

A1 Journal Article in MULTIPLE SCLEROSIS AND RELATED DISORDERS

Prediction of multiple sclerosis outcomes when switching to ocrelizumab

Michael ZhongAnneke van der WaltJim StankovichTomas KalincikKatherine BuzzardOlga SkibinaCavit BozSuzanne HodgkinsonMark SleeJeannette Lechner-Scott et al.

A1 Journal Article in MULTIPLE SCLEROSIS JOURNAL

2021

Alemtuzumab in multiple sclerosis : a retrospective analysis of occult hemorrhagic magnetic resonance imaging lesions and risk factors

Helen BachmannMelissa CambronJW CasselmanVeroniek Van DriesscheEline Van HauteLiesbeth Van HijfteTim KeldermanDimitri HemelsoetGuy Laureys

A1 Journal Article in EUROPEAN JOURNAL OF NEUROLOGY

2020

End of dose interval symptoms in patients treated with natalizumab : a role for serum cytokines?

Cathérine DekeyserAnnelien De PueAnne SiebenLuc AlgoedLiesbeth Van HijfteSarah GerloGuy Laureys

A1 Journal Article in MULTIPLE SCLEROSIS AND RELATED DISORDERS